company overview
About Us
Akimbo Health is a team of life sciences consultants helping bio-pharma companies develop and commercialize life-saving therapies for patients worldwide.
We specialize in new product planning and go-to-market strategies, helping biotech companies anticipate and navigate the complexities of developing and launching new products inside and outside the U.S.
Quality over quantity
At Akimbo, we believe every project is unique and deserves a tailored approach. By systematically collaborating with industry and subject matter experts—‘handpicked’ for each engagement—we assemble the perfect blend of expertise to tackle complex challenges.
Our leadership team is hands-on in every project, ensuring consistent quality and thoughtful delivery. With Akimbo, who you see is who you get: a dedicated, expert team committed to delivering efficient, meaningful solutions.
The Leadership
Julius Steffen
Julius is a seasoned healthcare management consultant with over 10 years of experience advising emerging biotechs and large pharma organizations on new product planning and commercial strategy topics.
Linah Richer
Linah has 10+ years of experience in life sciences, with specific interest and passion for new product planning for early-stage pipelines and companies.
Sherry is an experienced consultant with 15+ years of experience of helping biopharma companies with commercial operations and data analytics.
Aditya Pawar
Aditya is a seasoned consulting and operations professional with 13+ years of experience of helping biopharma clients with data science, portfolio strategy and commercial operations.
Featured Team Members
Meet select members of our consulting team
Victoria Schmidt-Liermann
10+ years experience; focused on market research and insights generation
Amy Serota
15+ years of experience; expert in market assessments and commercial strategy.
Michael Powers
PhD and postdoc; passionate about scientific and clinical due diligence.
Matha Nagababu
PhD and postdoc; focus: market insights and competitive intelligence
Olivia Hunter
Medically trained; focused on market research and insights generation
Subject Matter Experts
We hand-pick industry experts and subject matter experts with the right blend of experience for each individual project.
Meet two valued members of our advisory panel below
1/2
Michele Korfin
"Companies cannot wait until launch to develop the commercialization plan. An early commercial vision for the company and for each individual therapy are key to assuring a positive patient experience."
Michele brings 30+ years of experience in the biopharma industry with C-suite roles including CCO/COO at Gamida Cell and VP Market Access at Kite. Her tremendous experience in building companies and launching highly complex and innovative therapies makes Michele and invaluable thought partner to emerging biotech organizations.
2/2
Edmund Pezalla
"Collecting payer feedback early in the clinical development process ensures you generate the evidence needed to optimize coverage and pricing down the line."
Ed is a thought leader in the field of US market access and pricing. He served for nine years as VP for Pharmaceutical Policy and Strategy for Aetna, and four years as VP of Clinical Services for RxSolutions. He has advised many emerging and mature biopharma companies on some of the most innovative product launches in recent history.